Browsing by Author "AZD2816 Study Group"

Now showing items 1-1 of 1

Immunogenicity and safety of beta variant COVID-19 vaccine AZD2816 and AZD1222 (ChAdOx1 nCoV-19) as primary-series vaccination for previously unvaccinated adults in Brazil, South Africa, Poland, and the UK : a randomised, partly double-blinded, phase 2/3 non-inferiority immunobridging study

Clemens, Sue Ann Costa; Sprinz, Eduardo; Sorio, Guilherme Geraldo Lovato; Green, Justin A.; AZD2816 Study Group (2024) [Journal article]

Background: AZD2816 is a variant-adapted COVID-19 vaccine that expresses the full-length SARS-CoV-2 beta variant spike protein but is otherwise similar to AZD1222 (ChAdOx1 nCoV-19). This study aimed to evaluate the safety ...